Back to Search
ROLF BARTH, MD
MD
Specialist
NPI: 1144326414Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.
PMID 19588228·J Neurooncol·2009
7-preclinical
Boron neutron capture therapy at the crossroads: challenges and opportunities.
PMID 19467879·Appl Radiat Isot·2009
6-review
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
PMID 19381449·J Neurooncol·2009
6-review
Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.
PMID 18981415·Proc Natl Acad Sci U S A·2008
7-preclinical
REMOVED: Boron neutron capture therapy in the treatment of glioblastoma: As effective, more effective or less effective than photon irradiation?
PMID 16684574·Radiother Oncol·2006
8-other
Boron neutron capture therapy of cancer: current status and future prospects.
PMID 15930333·Clin Cancer Res·2005
6-review
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.
PMID 15308165·Appl Radiat Isot·2004
7-preclinical
Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
PMID 15342417·Cancer Res·2004
7-preclinical
Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
PMID 14697448·Int J Radiat Oncol Biol Phys·2004
7-preclinical
Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
PMID 12036929·Cancer Res·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 410 W 10TH AVE
COLUMBUS, OH 43210 - Phone
- (614) 292-2177
Quick Facts
- NPI
- 1144326414
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile